Biotechnology has been growing exponentially across all segments of the industry. It is estimated that the global market will command $727.1 Billion USD by 2025.
ToxSorb’s project objective was ambitious: Design a cost-effective, high quality chemistry control sequence while managing the full process, from design to commissioning, in-house. And the kicker? With no in-house control engineers, ToxSorb’s process engineers would have to do it all.
A key challenge for biotech companies is the progression from research to scale production. There are a number of reasons biotech companies find it challenging to industrialize, but all of them can be overcome with the right automation partner.
Consistent methodology within complex systems is all around us. And finding a methodology for developing and programming software for PLCs shouldn’t be an exception.
PLC code is much more about software than it is about electrical engineering. In fact, the root cause of many industrial control system failures and incidents lies in failure to understand that we are dealing with software.
Control engineers have been coding PLCs the same way for a long (long) time. With the arrival of younger engineers and the spread of Industry 4.0, we’re finally on the verge of real change.
There is a serious disconnect between process and control engineering. Improving knowledge transfer between the two disciplines would have a measurable effect on efficiency, safety, and productivity.
Industrial safety has come a long way in the last forty years but further improvement is still needed. For instance, programming flaw accounted for 20% of the root causes of processing accidents!
Extra! Extra! WonderLogix was awarded a €1.9M ($2.2M USD) equity-free investment from the EU’s Horizon 2020 SME Instrument program!! This trailblazing initiative finances the most innovative, high growth potential small companies, all over the world.